Clinical Trials Browser

INDUSTRY × Lymphoma, Mantle-Cell × palbociclib × Clear all

NCT00420056 2015-10-28

An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.

Phase 1 Completed

17 enrolled 22 charts

Lymphoma, Mantle-Cell